Biofrontera Inc. Warrants
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with t… Read more
Market Cap & Net Worth: Biofrontera Inc. Warrants (BFRIW)
Biofrontera Inc. Warrants (NASDAQ:BFRIW) has a market capitalization of $489.17 ($489.17) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #37541 globally and #12239 in its home market, demonstrating a 26.70% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biofrontera Inc. Warrants's stock price $0.05 by its total outstanding shares 9371 (9.37K).
Biofrontera Inc. Warrants Market Cap History: 2021 to 2026
Biofrontera Inc. Warrants's market capitalization history from 2021 to 2026. Data shows change from $33.74K to $489.17 (-49.03% CAGR).
Biofrontera Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biofrontera Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Biofrontera Inc. Warrants's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $33.74K | $24.10 Million | -$37.71 Million | 0.00x | N/A |
| 2022 | $1.88K | $28.67 Million | -$640.00K | 0.00x | N/A |
| 2023 | $93.71 | $34.07 Million | -$20.13 Million | 0.00x | N/A |
| 2024 | $568.82 | $37.30 Million | -$17.76 Million | 0.00x | N/A |
Competitor Companies of BFRIW by Market Capitalization
Companies near Biofrontera Inc. Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Biofrontera Inc. Warrants by market ranking:
- NGS Group AB (publ) (ST:NGS): Ranked #37532 globally with a market cap of $488.82K USD ( Skr5.48 Million SEK).
- DMG MORI SEIKI (MU:GIL): Ranked #37533 globally with a market cap of $488.58K USD ( €475.98K EUR).
- EUWAX AG (MU:EUX): Ranked #37542 globally with a market cap of $486.04K USD ( €473.51K EUR).
- Formuepleje Mix High (CO:FPIMHI): Ranked #37543 globally with a market cap of $484.84K USD ( Dkr3.52 Million DKK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #37532 | NGS Group AB (publ) | ST:NGS | $488.82K | Skr2.33 |
| #37533 | DMG MORI SEIKI | MU:GIL | $488.58K | €48.20 |
| #37542 | EUWAX AG | MU:EUX | $486.04K | €48.80 |
| #37543 | Formuepleje Mix High | CO:FPIMHI | $484.84K | Dkr386.60 |
Biofrontera Inc. Warrants Historical Marketcap From 2021 to 2026
Between 2021 and today, Biofrontera Inc. Warrants's market cap moved from $33.74K to $ 489.17, with a yearly change of -49.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $489.17 | -42.00% |
| 2025 | $843.39 | +48.27% |
| 2024 | $568.82 | +507.00% |
| 2023 | $93.71 | -95.03% |
| 2022 | $1.88K | -94.41% |
| 2021 | $33.74K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Biofrontera Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $489.17 USD |
| MoneyControl | $489.17 USD |
| MarketWatch | $489.17 USD |
| marketcap.company | $489.17 USD |
| Reuters | $489.17 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.